Investigators report on trends in treatment of advanced-stage NSCLC from 2000 to 2011, including impact on survival and total Medicare spending.
A study presented at the World Conference on Lung Cancer compared progression-free survival after treatment with osimertinib with that of platinum therapy plus pemetrexed in a select group of patients with T790M-positive advanced NSCLC.
Nearly half of patients with advanced cancer around the world believe they will be cured, with the perception of curability significantly differing by education, performance status, and country of origin.
Treatment with methylnaltrexone was associated with improved overall survival in patients with advanced cancer.
Despite the infrequency of urine drug test ordering, greater than half of all urine drug tests results were abnormal among outpatients with advanced cancer.
Increasing body mass index (BMI) allows growth and progression of disease in patients with multiple myeloma, a recently published study has shown.
Advanced Cancer Patients Often Unaware That They Are More Optimistic About Their Prognosis Than Their OncologistsJuly 27, 2016
Most patients with advanced cancer report far more optimistic expectations for survival prognosis than their oncologists because patients misunderstand their oncologists' clinical judgment.
MYL-1401O is comparable in efficacy and safety to the anti-HER2 monoclonal antibody trastuzumab as frontline therapy in breast cancer.
A Web application called Moovcare that guides follow-up improved survival for patients with advanced lung cancer after receiving initial therapy.
Patients participating in early-phase clinical trials should be assessed for sleep quality, as poor sleep quality is associated with greater fatigue, symptom burden, and mood disturbance.
Managing pain with opioids and keeping a close eye on adverse effects is an important part of cancer care. But there is room for improvement in pain management tools, and nurses play a key role in their evolution.
In addition to improving overall survival compared with dacarbazine in patients with advanced melanoma, nivolumab maintains baseline levels of health-related quality of life to ultimately confer long-term quality of survival benefit.
Immunotherapy for advanced ovarian cancer more effectively treats tumors when administered immediately after chemotherapy. Sequential chemoimmunotherapy could improve disease control in stage IIIC/IV tubo-ovarian HGSC.
The genetically engineered epothilone analog, utidelone, in combination with capecitabine significantly improved progression-free survival and objective response rates in patients with metastatic breast cancer who were heavily pretreated, compared with capecitabine alone, results of a phase 3 trial presented at the 2016 ASCO Annual Meeting have shown.
A blood-based test pinpoints which patients with metastatic colorectal cancer will benefit from treatment with cetuximab.
The Bim protein might predict which patients could be successfully treated with immunotherapy for metastatic melanoma.
A recent study examined depression and anxiety among family caregivers of patients with incurable cancer and sought to identify factors linked to these symptoms.
Despite the benefits of early palliative care intervention, palliative care is less frequently employed at the emergency department. Researchers sought to evaluate patient outcomes related to ED palliative care.
White wine does not improve appetite or weight in patients with advanced cancer, a recent study has shown.
A recently developed biomarker test for patients with advanced colorectal cancer could help determine the best treatment options for each patient.
An exercise intervention did not improve physical functioning for women living with advanced breast cancer, according to a study.
Moderate exercise intervention did not appear to improve physical functioning in women with advanced breast cancer to a significant degree, according to study data.
Patients with advanced cancer view life goals as distinct from and less important than treatment goals, according to a recent study.
Initiating a palliative care consultation in the ED improved quality of life and survival was not shortened in patients with advanced cancer.
[Breast Cancer: Basic and Clinical Research] This research examines previous recent research on the therapeutic effects and adversities of eribulin monotherapy and eribulin-based combination therapy for breast cancer treatment.
Adolescents and young adults (AYAs) with hematologic malignancies experience significant psychological morbidities during treatment and early survivorship.
International Experts Call for Investigations Into Long-Term Management Options for Select Patients With Advanced Breast CancerNovember 19, 2015
International experts have called for a clinical trial to investigate the best ways for identifying and treating a small but important group of patients with advanced breast cancer who can survive for long periods without their disease progressing.
Patients With Advanced Breast Cancer Address an International Conference About Misleading Disease-Specific MessagesNovember 19, 2015
Patients with advanced breast cancer spoke out about the damaging messages some organizations issue about advanced breast cancer. They need to be identified and educated to change the way they talk about the disease.
Approved for use with PD-L1 IHC 22C3 pharmDx test
Oral melatonin at a dose of 20 mg was not associated with improvement in fatigue or other symptoms in patients with advanced cancer.
- Ruxolitinib May Improve Symptom Control in Patients With CLL
- Obesity Increases Risk for Transformation of MGUS to Multiple Myeloma
- Racial Disparities Persist in Myeloma Treatment Use
- Adding Bortezomib to Rd Improves PFS, OS in Newly Diagnosed Myeloma
- Lutetium-177 Dotatate Improves PFS in Advanced Midgut Carcinoid Tumors
- Optimal Timing of Influenza Vaccination in Patients Receiving Chemotherapy
- Racial Disparities Persist in Myeloma Treatment Use
- Hypnosis and Its Use in Cancer Treatment
- Longer Dosing Interval of Zoledronic Acid May Be Acceptable for Bone Metastases
- Patients With Breast Cancer Report More Cognitive Difficulties After Chemotherapy
- No Differences in Lung Cancer Mutations Between White, Black Patients
- Second-line Weekly Nab-paclitaxel Noninferior to Paclitaxel for Gastric Cancer
- Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
- Role of Oncology Nurse Navigators Has Evolved and Expanded in 5 Years
- Frailty Classifications Associated With Prognosis Among Older Patients
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|